De-Escalation of Treatment in Women Aged ≥80 Years with Breast Cancer: A Retrospective Analysis from Two Breast Centers
Breast surgery, when possible, has a primary role even for women > 80 years of age, and it is associated with a reasonable BCSS. De-escalation of adjuvant therapies should be considered in this setting because survival is largely determined by age and co-morbidities.
Authors
- Gianmarco Piccolino
- Emanuele Zarba Meli (ORCID: https://orcid.org/0000-0001-7190-2974)
- Tiziana Mastropietro
- Elena Manna
- Augusto Lombardi (ORCID: https://orcid.org/0000-0002-4520-0183)
- Lorenzo Palleschi (ORCID: https://orcid.org/0000-0002-8056-0547)
- Francesca Arienzo (ORCID: https://orcid.org/0000-0002-6335-5920)
- Valeria Vitale (ORCID: https://orcid.org/0000-0003-1073-3390)
- Lucio Fortunato (ORCID: https://orcid.org/0000-0002-8252-5833)
- Elena Del Giudice
- Andrea Loreti (ORCID: https://orcid.org/0009-0000-7378-8431)
- Laura Broglia
- Rosalinda Rossi
- Leopoldo Costarelli (ORCID: https://orcid.org/0000-0002-9545-8123)
- Claudia Scaringi
- Federica Bergamo (ORCID: https://orcid.org/0009-0001-5351-5070)
- Massimo La Pinta
- Giulia Cardelli
Institutions
- University of Rome Tor Vergata (IT)
- Azienda Ospedaliera San Giovanni Addolorata (IT)
- Azienda Ospedaliera Sant'Andrea (IT)
Publication Details
- Journal
- Current Oncology
- Published
- 2025-08-28
- DOI
- https://doi.org/10.3390/curroncol32090482
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00